2017
DOI: 10.4314/tjpr.v16i1.31
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the causes and cost impact of returned intravenous medications at a tertiary care hospital in Riyadh, Saudi Arabia

Abstract: Purpose: To evaluate the main reasons for returning intravenous (IV) medications and to determine its cost impact in an in

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(24 citation statements)
references
References 12 publications
1
21
0
2
Order By: Relevance
“…4,5 In addition, dispensing of an extra quantity of medication, switching from intravenous therapy to oral, patient discharge, refill order, patient expiration (death), and patient objection to take the dose were the most common reasons for the nonutilization of medications in the inpatient wards of health facilities. 6,7…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…4,5 In addition, dispensing of an extra quantity of medication, switching from intravenous therapy to oral, patient discharge, refill order, patient expiration (death), and patient objection to take the dose were the most common reasons for the nonutilization of medications in the inpatient wards of health facilities. 6,7…”
Section: Introductionmentioning
confidence: 99%
“…The study has also revealed that the most frequently returned classes of medications were antibiotics 47.11%, electrolyte replacement preparations 17.27%, gastrointestinal drugs 6.55%, analgesics and antipyretics, 5.19%, and blood derivatives 4.51%. 7…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…CE is not explicitly referenced in the PSC literature, although the idea of circularity or CLSC is presented as reuse (Alhamad et al, 2018;Connelly, 2018), return of medicines (Daniszewsi et al, 2002;AlSamanhodi et al, 2017) and even in the market of medical devices (Bange and Morgan, 2018). Søndergaard et al (2006) argue that the practice of medicines returns for reuse can reduce overall health costs and time at hospital, although with no positive impacts for medicines market prices.…”
Section: Circular Economy (Ce) and Clsc Involving Eou-mmentioning
confidence: 99%
“…6 Pembuangan obat juga menyumbang proporsi besar terhadap biaya perawatan kesehatan yang semakin meningkat di seluruh dunia. 7 Hal ini menggambarkan hilangnya kesempatan untuk meningkatkan kesehatan pada pasien yang terlibat dalam pemborosan biaya kesehatan yang seharusnya bisa digunakan untuk membiayai perawatan kesehatan yang sangat dibutuhkan. 5 Berdasarkan analisis studi lebih lanjut tentang obat-obatan yang tidak digunakan menunjukkan implikasi ekonomi yang tinggi bagi pembayar, mungkin juga ada biaya tidak langsung karena efektivitas yang terbatas dan kegagalan terapi, efek yang tidak diinginkan dari penggunaan obat yang salah sehingga pada akhirnya berdampak negatif pada morbiditas dan mortalitas.…”
Section: Pendahuluanunclassified